Avian influenza: Virology, diagnosis and surveillance

Future Microbiology

Volumn 8, Issue 9, 2013, Pages 1209-1227

  El Zowalaty, Mohamed E ^a,b,c   Bustin, Stephen A ^a   Husseiny, Mohamed I ^c,d   Ashour, Hossam M ^e,f  

^a ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c Zagazig University   (Egypt)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f CAIRO UNIVERSITY   (Egypt)

Author keywords

avian influenza; diagnosis; real time PCR; surveillance; vaccines; virus isolation; waterfowl

Indexed keywords

ANTIVIRUS AGENT; COMPLEMENTARY DNA; DNA VACCINE; INFLUENZA VACCINE; MESSENGER RNA; NAKED DNA;

AMNION FLUID; ANTIGEN EXPRESSION; ANTIVIRAL THERAPY; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; AVULAVIRUS; BASE PAIRING; CHARADRIIFORMES; CHEMICAL STRUCTURE; COMPLEMENT FIXATION; CYTOPATHOGENIC EFFECT; DISEASE SURVEILLANCE; DNA IMMUNIZATION; EDUCATION PROGRAM; GENE GUN; HONG KONG INFLUENZA; HUMAN; IMMUNOFLUORESCENCE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MORBIDITY; MORTALITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PANDEMIC INFLUENZA; POULTRY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SALMONELLA TYPHIMURIUM; SEASONAL INFLUENZA; SEROEPIDEMIOLOGY; SPANISH INFLUENZA; TYPE III SECRETION SYSTEM; VIRION; VIROLOGY; VIRUS CLASSIFICATION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; BIRDS; COMMUNICABLE DISEASE CONTROL; EPIDEMIOLOGICAL MONITORING; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; POULTRY; ZOONOSES;

EID: 84884140717     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.81     Document Type: Review

References (205)

1. World Organization for Animal Health. Avian influenza. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds, and Bees. (6th Edition, Volume 1). Office International des Epizooties, France, 465-481 (2008).
2. Swayne DE. The global nature of avian influenza. In: Avian Influenza. Wiley-Blackwell, NJ, USA, 126-127 (2009).
3. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 348(9031), 901-902 (1996).
4. Webster RG, Geraci J, Petursson G, Skirnisson K. Conjunctivitis in human beings caused by influenza A virus of seals. N. Engl. J. Med. 304(15), 911 (1981).
5. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Mol. Biol. Rev. 56(1), 152-179 (1992).
6. Kilbourne ED. Influenza immunity: new insights from old studies. J. Infect. Dis. 193(1), 7-8 (2006).
7. Lindstrom S, Cox N, Klimov A. Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology 328(1), 101-119 (2004).
8. Palese P Shaw ML. Orthomyxoviridae: the viruses and their replication. In: Fields' Virology. Knipe DM, Howley PM, Griffin DM, Lamb RA, Martin MA (Eds). Lippincott, Williams & Wilkins, PA, USA, 1647-1689 (2007).
9. Capua I, Alexander DJ. Avian influenza and human health. Acta Tropica 83(1), 1-6 (2002).
10. Saif YM. Diseases of Poultry. Iowa State Press, IA, USA (2003).
11. Arzt J, White W, Thomsen B, Brown C. Agricultural diseases on the move early in the third millennium. Vet. Pathol. 47(1), 15-27 (2010).
12. El Zowalaty ME, Abin M, Chander Y, Redig PT, Goyal SM. Isolation of H5 avian influenza viruses from waterfowl in the upper midwest region of the United States. Avian Dis. 55(2), 259-262 (2011).
13. El Zowalaty ME, Abin M, Raju S et al. Isolation of avian influenza virus from polymerase chain reaction-negative cloacal samples of waterfowl. J. Vet. Diagn. Invest. 23(1), 87-90 (2011).
14. Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937), 197-201 (2009).
15. Mounts AW, Kwong H, Izurieta HS et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J. Infect. Dis. 180(2), 505-508 (1999).
16. Alexander DJ. Avian influenza: historical aspects. Avian Dis. 47, 4-13 (2003).
17. Lupiani B, Reddy SM. The history of avian influenza. Comp. Immunol. Microbiol. Infect. Dis. 32(4), 311-323 (2009).
18. Nichols JE, Leduc JW. Influenza. In: Vaccines for Biodefense and Emerging and Neglected Diseases. Barrett AT, Stanberry LR (Eds). Academic Press, Waltham, MA, USA, 497-525 (2008).
19. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 'Spanish' influenza virus. Science 275(5307), 1793-1796 (1997).
20. Taubenberger J, Morens D. 1918 Influenza: the mother of all pandemics. Emerg. Infect. Dis. 12(1), 15-22 (2006).
21. Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine 21(16), 1801-1803 (2003).
22. Hehme N, Engelmann H, Künzel W, Neumeier E, Sänger R. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med. Microbiol. Immunol. 191(3-4), 203-208 (2002).
23. Newcastle disease. In: Manual of Standards for Diagnostic Tests and Vaccines. Office International des Epizooties, France, 161-169 (1996).
24. Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325(5937), 197-201 (2009).
25. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5(1), e8553 (2010).
26. Smith GJ, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459(7250), 1122-1125 (2009).
27. Zhang W, Qi J, Shi Y et al. Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus. Protein Cell 1(5), 459-467 (2010).
28. Perez-Padilla R. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 361(7), 680-689 (2009).
29. Smith GJ, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459(7250), 1122-1125 (2009).
30. Centanni ESE. La peste aviaria I & II. Communicazione fatta all'accademia delle scienze mediche e naturali de Ferrara. (1901).
31. Stubs EL, Biester HE, Devries L. Fowl pest. In: Diseases of Poultry. Iowa State Press, IA, USA, 493-502 (1952).
32. Perroncito E. Epizoozia tifoide nei gallinacei. Ann. Accad. Agric. Torino. 126, 21-87 (1878).
33. Becker WB. The isolation and classification of tern virus: influenza virus A/tern/South Africa/1961. J. Hyg. (Lond.) 64(3), 309-320 (1966).
34. Subbarao K, Klimov A, Katz J et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279(5349), 393-396 (1998).
35. Webster RG. Predictions for future human influenza pandemics. J. Infect. Dis. 176(Suppl. 1), S14-S19 (1997).
36. Guo Y, Xu X, Wan X. [Genetic characterization of an avian influenza A (H5N1) virus isolated from a sick goose in China]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 12(4), 322-325 (1998).
37. Claas EC, Osterhaus AD, van Beek R et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351(9101), 472-477 (1998).
38. Mounts AW, Kwong H, Izurieta HS et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J. Infect. Dis. 180(2), 505-508 (1999).
39. Peiris JS, Yu WC, Leung CW et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363(9409), 617-619 (2004).
40. Banner D, Kelvin AA. The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development. J. Infect. Dev. Ctries 6(06), 465-469 (2012).
41. Bartlett JG. Planning for avian influenza. Ann. Intern. Med. 145(2), 141-144 (2006).
42. Li Q, Zhou L, Zhou M et al. Preliminary report. epidemiology of the avian influenza A (H7N9) outbreak in China. N. Engl. J. Med. doi:10.1056/ NEJMoa1304617 (2013) (Epub ahead of print).
43. Liu D, Shi W, Shi Y et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381(9881), 1926-1932 (2013).
44. Zhu H WD, Kelvin Dj, Li L et al. Infectivity, transmission, and pathology of human H7N9 influenza in ferrets and pigs. Science 341(6142), 183-186 (2013).
45. Uyeki TM, Cox NJ. Global concerns regarding novel influenza A (H7N9) virus infections. N. Engl. J. Med. 368(20), 1862-1864 (2013).
46. Easterday BC. Animals in the influenza world. Phil. Trans. R. Soc. Lond. 288(1029), 433-437 (1980).
47. Daly JM, Blunden AS, Macrae S et al. Transmission of equine influenza virus to English foxhounds. Emerg. Infect. Dis. 14(3), 461-464 (2008).
48. Song D, Kang B, Lee C et al. Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 14(5), 741-746 (2008).
49. Herfst S, Schrauwen EJ, Linster M et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336(6088), 1534-1541 (2012).
50. Imai M, Watanabe T, Hatta M et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403), 420-428 (2012).
51. Berns KI, Casadevall A, Cohen ML et al. Adaptations of avian flu virus are a cause for concern. Science 335(6069), 660-661 (2012).
52. Baltimore D. Expression of animal virus genomes. Bacteriol. Rev. 35(3), 235-241 (1971).
53. Virology Division International Union of Microbiological Societies. Virus Taxonomy. Eighth Report of the International Committee on the Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger, Ball LA (Eds). Academic Press, MA, USA (2005).
54. MacLachlan NJ, Dubovi EJ. Orthomyxoviridae. In: Fenner's Veterinary Virology (4th Edition). Academic Press, MA, USA, 353-370 (2011).
55. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Phil. Trans. R. Soc. Lond. 356(1416), 1861-1870 (2001).
56. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 26, D49-D53 (2008).
57. Steinhauer D, Skehel J. Genetics of influenza viruses. Annu. Rev. Genet. 36, 305-332 (2002).
58. García-Sastre A. The neuraminidase of bat influenza viruses is not a neuraminidase. Proc. Natl Acad. Sci. USA 109(46), 18635-18636 (2012).
59. Tong S, Li Y, Rivailler P et al. A distinct lineage of influenza A virus from bats. Proc. Natl Acad. Sci. USA 109(11), 4269-4274 (2012).
60. A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull. World Health Organ. 58(4), 585-591 (1980).
61. Fouchier RA, Munster V, Wallensten A et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79(5), 2814-2822 (2005).
62. [A revised system of nomenclature for influenza A viruses: WHO report]. Bull. World Health Organ. 57(4), 611-617 (1979).
63. Fauci AS. Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell 124(4), 665-670 (2006).
64. Zambon MC. Epidemiology and pathogenesis of influenza. J. Antimicrob. Chemother. 44(Suppl. B), 3-9 (1999).
65. Desselberger U, Nakajima K, Alfino P et al. Biochemical evidence that new influenza virus strains in nature may arise by recombination (reassortment). Proc. Natl Acad. Sci. USA 75(7), 3341-3345 (1978).
66. Olsen B, Munster VJ, Wallensten A, Waldenström J, Osterhaus AD, Fouchier RA. Global patterns of influenza A virus in wild birds. Science 312(5772), 384-388 (2006).
67. Capua I, Alexander DJ. Avian influenza infections in birds a moving target. Influenza Other Respi. Viruses 1(1), 11-18 (2007).
68. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog. 9(2), e1003151 (2013).
69. Senne DA, Panigrahy B, Kawaoka Y et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis. 40(2), 425-437 (1996).
70. Vey M, Orlich M, Adler S, Klenk HD, Rott R, Garten W. Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology 188(1), 408-413 (1992).
71. Wood GW, McCauley JW, Bashiruddin JB, Alexander DJ. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes. Arch. Virol. 130(1-2), 209-217 (1993).
72. Stieneke-Gröber A, Vey M, Angliker H. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11(7), 2407-2414 (1992).
73. Alexander DJ. An overview of the epidemiology of avian influenza. Vaccine 25(30), 5637-5644 (2007).
74. Bogs J, Veits J, Gohrbandt S et al. Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS ONE 5(7), e11826 (2010).
75. Gohrbandt S, Veits J, Hundt J et al. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. J. Gen. Virol. 92(1), 51-59 (2011).
76. Hatta M, Kawaoka Y. The NB protein of influenza B virus is not necessary for virus replication in vitro. J. Virol. 77(10), 6050-6054 (2003).
77. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8(9), 950-954 (2002).
78. Hinshaw VS, Webster RG, Turner B. The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Can. J. Microbiol. 26(5), 622-629 (1980).
79. El Zowalaty ME, Abin M, Chander Y, Redig PT, Goyal SM. Improved method for the isolation and sub-typing of avian influenza viruses from oropharyngeal samples of ducks. Avian Dis. 55(3), 439-442 (2011).
80. Stallknecht DE. Ecology and epidemiology of avian influenza viruses in wild bird populations: waterfowl, shorebirds, pelicans, cormorants, etc. Avian Dis. 47(Special Issue), 61-69 (2003).
81. Charlton B, Crossley B, Hietala S. Conventional and future diagnostics for avian influenza. Comp. Immunol. Microbiol. Infect. Dis. 32(4), 341-350 (2009).
82. Peiris JM, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20(2), 243-267 (2007).
83. Webby R, Hoffmann E, Webster R. Molecular constraints to interspecies transmission of viral pathogens. Nat. Med. 10, S77-S81 (2004).
84. Couceiro J, Paulson JC, Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29(2), 155-165 (1993).
85. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 440(7083), 435-436 (2006).
86. Matrosovich M, Zhou N, Kawaoka Y, Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73(2), 1146-1155 (1999).
87. Beare AS. Replication of avian influenza viruses in humans. Arch. Virol. 119(1-2), 37-42 (1991).
88. Hinshaw VS, Webster RG, Naeve CW, Murphy BR. Altered tissue tropism of human-avian reassortant influenza viruses. Virology 128(1), 260-263 (1983).
89. Ito T, Couceiro JN, Kelm S et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72(9), 7367-7373 (1998).
90. Slemons RD, Easterday BC. Virus replication in the digestive tract of ducks exposed by aerosol to type-A influenza. Avian Dis. 22(3), 367-377 (1978).
91. Kim JK, Negovetich NJ, Forrest HL, Webster RG. Ducks: the trojan horses of H5N1 influenza. Influenza Other Respi. Viruses 3(4), 121-128 (2009).
92. Janies D, Hill AW, Guralnick R, Habib F, Waltari E, Wheeler WC. Genomic analysis and geographic visualization of the spread of avian influenza (H5N1). Syst. Biol. 56(2), 321-329 (2007).
93. Ollier L, Caramella A, Giordanengo V, Lefebvre JC. High permissivity of human HepG2 hepatoma cells for influenza viruses. J. Clin. Microbiol. 42(12), 5861-5865 (2004).
94. Perez DR, Sorrell EM, Donis RO. Avian influenza: an omnipresent pandemic threat. Pediatr. Infect. Dis. J. 24(11 Suppl.), S208-S216 (2005).
95. Ferro PJ, El-Attrache J, Fang X et al. Avian influenza surveillance in hunter-harvested waterfowl from the gulf coast of Texas (November 2005-January 2006). J. Wildl. Dis. 44(2), 434-439 (2008).
96. Furuse Y, Suzuki A, Kamigaki T, Oshitani H. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol. J. 6, 67 (2009).
97. Munster VJ, Fouchier RA. Avian influenza virus: of virus and bird ecology. Vaccine 27(45), 6340-6344 (2009).
98. Pedersen K, Swafford SR, Deliberto TJ. Low pathogenicity avian influenza subtypes isolated from wild birds in the United States, 2006-2008. Avian Dis. 54(1 Suppl.), 405-410 (2010).
99. Hua YP, Chai HL, Yang SY, Zeng XW, Sun Y. Primary survey of avian influenza virus and Newcastle disease virus infection in wild birds in some areas of Heilongjiang Province, China. J. Vet. Sci. 6(4), 311-315 (2005).
100. Stallknecht DE, Shane SM, Zwank PJ, Senne DA, Kearney MT. Avian influenza viruses from migratory and resident ducks of coastal Louisiana. Avian Dis. 34(2), 398-405 (1990).
101. Douglas KO, Lavoie MC, Kim LM, Afonso CL, Suarez DL. Isolation and genetic characterization of avian influenza viruses and a Newcastle disease virus from wild birds in Barbados: 2003-2004. Avian Dis. 51(3), 781-787 (2007).
102. El Zowalaty ME, Chander Y, Redig PT, El Latif HKA, El Sayed MA, Goyal SM. Selective isolation of Avian influenza virus (AIV) from cloacal samples containing AIV and Newcastle disease virus. J. Vet. Diagn. Invest. 23(2), 330-332 (2011).
103. Hinshaw VS, Wood JM, Webster RG, Deibel R, Turner B. Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America. Bull. World Health Organ. 63(4), 711-719 (1985).
104. Jahangir A, Ruenphet S, Ueda S et al. Avian influenza and Newcastle disease viruses from northern pintail in Japan: isolation, characterization and inter-annual comparisons during 2006-2008. Virus Res. 143(1), 44-52 (2009).
105. Slemons RD, Johnson DC, Osborn JS, Hayes F. Type-A influenza viruses isolated from wild free-flying ducks in California. Avian Dis. 18(1), 119-124 (1974).
106. Slemons RD, Shieldcastle MC, Heyman LD, Bednarik KE, Senne DA. Type A influenza viruses in waterfowl in Ohio and implications for domestic turkeys. Avian Dis. 35(1), 165-173 (1991).
107. Lira J, Moresco KA, Stallknecht DE, Swayne DE, Fisher DS. Single and combination diagnostic test efficiency and cost analysis for detection and isolation of avian influenza virus from wild bird cloacal swabs. Avian Dis. 54(Suppl. 1), 606-612 (2010).
108. Weinberg A, Mettenbrink CJ, Ye D, Yang CF. Sensitivity of diagnostic tests for influenza varies with the circulating strains. J. Clin. Virol. 33(2), 172-175 (2005).
109. Philippa JD. Avian influenza. In: Zoo and Wild Animal Medicine Current Therapy (6th Edition). Fowler ME (Ed.). Saunders, PA, USA, 79-87 (2008).
110. Swayne DE, Suarez DL. Highly pathogenic avian influenza. Rev. Sci. Tech. 19(2), 463-482 (2000).
111. Suarez DL, Das A, Ellis E. Review of rapid molecular diagnostic tools for avian influenza virus. Avian Dis. 51(1 Suppl.), 201-208 (2007).
112. Ellström P, Latorre-Margalef N, Griekspoor P et al. Sampling for low-pathogenic avian influenza A virus in wild mallard ducks: oropharyngeal versus cloacal swabbing. Vaccine 26(35), 4414-4416 (2008).
113. Jindal N, De Abin M, Primus AE et al. Comparison of cloacal and oropharyngeal samples for the detection of avian influenza virus in wild birds. Avian Dis. 54(1), 115-119 (2010).
114. Roelandt S, Outtrim L, Browning C, Alexander DJ, Brown IH, Irvine RM. Evaluation of two different swab transport systems in the detection of avian influenza virus excretion from infected pekin ducks Anas platyrhynchos. J. Virol. Methods 184(1-2), 8-14 (2012).
115. WHO. Laboratory procedures. In: WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO Press, Switzerland, 98, 15-19 (2002).
116. Docherty DE, Slota PG. Use of muscovy duck embryo fibroblasts for the isolation of viruses from wild birds. Methods Cell Sci. 11(3), 165-170 (1988).
117. Taubenberger JK, Layne SP. Diagnosis of influenza virus: coming to grips with the molecular era. Mol. Diagn. 6(4), 291-305 (2001).
118. Potter C, Zuckerman AJ, Banatvala JE, Pattison JR. Influenza. In: Principles and Practice of Clinical Virology. Wiley, NY, USA, 199-223 (1987).
119. Newton DW, Treanor JJ, Menegus MA. Clinical and laboratory diagnosis of influenza virus infections. Am. J. Manag. Care 6(Suppl. 5), S265-S275 (2000).
120. Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J. Infect. Dis. 194(Suppl. 2), S98-S110 (2006).
121. Prince HE, Leber AL. Comparison of complement fixation and hemagglutination inhibition assays for detecting antibody responses following influenza virus vaccination. Clin. Vaccine Immunol. 10(3), 481-482 (2003).
122. Julkunen I, Pyhala R, Hovi T. Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis. J. Virol. Methods 10(1), 75-84 (1985).
123. Pearson JE, Senne DA. Diagnostic procedures for avian influenza. Avian Dis. 47, 222-227 (2003).
124. Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 2, 66-68 (1933).
125. Swayne DE, Senne DA, Suarez DL. Avian influenza. In: A Laboratory Manual for the Isolation, Identification, and Characterization of Avian Pathogens. Dufour-Zavala L (Ed.). American Association of Avian Pathologists, GA, USA, 128-134 (2008).
126. Cattoli G, Drago A, Maniero S et al. Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds. Avian Pathol. 33(4), 432-437 (2004).
127. Cattoli G, Capua I. Molecular diagnosis of avian influenza during an outbreak. Dev. Biol. (Basel) 124, 99-105 (2006).
128. Carman S, Stansfield C, Weber J, Bildfell R, Van Dreumel T. H3N2 influenza A virus recovered from a neonatal pig in Ontario-1997. Can. Vet. J. 40(12), 889-890 (1999).
129. Clavijo A, Tresnan DB, Jolie R, Zhou EM. Comparison of embryonated chicken eggs with MDCK cell culture for the isolation of swine influenza virus. Can. Vet. J. 66(2), 117-121 (2002).
130. Lee CW, Jung K, Jadhao S, Suarez D. Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses. J. Virol. Methods 153(1), 22-28 (2008).
131. Moresco KA, Stallknecht DE, Swayne DE. Evaluation and attempted optimization of avian embryos and cell culture methods for efficient isolation and propagation of low pathogenicity avian influenza viruses. Avian Dis. 54(1 Suppl.), 622-626 (2010).
132. Munster VJ, Baas C, Lexmond P et al. Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J. Clin. Microbiol. 47(3), 666-673 (2009).
133. Reina J, Fernandez-Baca V, Blanco I, Munar M. Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J. Clin. Microbiol. 35(7), 1900-1901 (1997).
134. Schultz-Cherry S, Dybdahl-Sissoko N, McGregor M, Hinshaw VS. Mink lung epithelial cells: unique cell line that supports influenza A and B virus replication. J. Clin. Microbiol. 36(12), 3718-3720 (1998).
135. Shope RE. Swine influenza : III. Filtration experiments and etiology. J. Exp. Med. 54(3), 373-385 (1931).
136. Webster RG. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch. Virol. 13, 105-113 (1997).
137. Fouchier RA, Bestebroer TM, Herfst S, van der Kemp L, Rimmelzwaan GF, Osterhaus AD. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol. 38(11), 4096-4101 (2000).
138. Allwinn R, Preiser W, Rabenau H, Buxbaum S, Stürmer M, Doerr HW. Laboratory diagnosis of influenza-virology or serology? Med. Microbiol. Immunol. 191(3-4), 157-160 (2002).
139. Espy MJ, Smith TF, Harmon MW, Kendal AP. Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J. Clin. Microbiol. 24(4), 677-679 (1986).
140. Stokes CE, Bernstein JM, Kyger SA, Hayden FG. Rapid diagnosis of influenza A and B by 24-h fluorescent focus assays. J. Clin. Microbiol. 26(7), 1263-1266 (1988).
141. Dunn JJ, Gordon C, Kelley C, Carroll KC. Comparison of the Denka-Seiken INFLU A.B-Quick and BD Directigen Flu A+B kits with direct fluorescent-antibody staining and shell vial culture methods for rapid detection of influenza viruses. J. Clin. Microbiol. 41(5), 2180-2183 (2003).
142. Chander Y, Jindal N, Stallknecht DE, Sreevatsan S, Goyal SM. Full length sequencing of all nine subtypes of the neuraminidase gene of influenza A viruses using subtype specific primer sets. J. Virol. Methods 165(1), 116-120 (2010).
143. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full length amplification of all influenza A viruses. Arch. Virol. 146(12), 2275-2289 (2001).
144. Jindal N, Chander Y, de Abin M et al. Amplification of four genes of influenza A viruses using a degenerate primer set in a one step RT-PCR method. J. Virol. Methods 160(1-2), 163-166 (2009).
145. Lee MS. Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J. Virol. Methods 97(1-2), 13-22 (2001).
146. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol. 29(1), 23-39 (2002).
147. Wacker MJ, Godard MP. Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J. Biomol. Tech. 16(3), 266-271 (2005).
148. Munch M, Nielsen LP, Handberg KJ, Jorgensen PH. Detection and subtyping (H5 and H7) of avian type A influenza virus by reverse transcription-PCR and PCR-ELISA. Arch. Virol. 146(1), 87-97 (2001).
149. Dybkær K, Munch M, Handberg KJ, Jørgensen PH. Application and evaluation of RT-PCR-ELISA for the nucleoprotein and RT-PCR for detection of low-pathogenic H5 and H7 subtypes of avian influenza virus. J. Vet. Diagn. Invest. 16(1), 51-56 (2004).
150. Collins RA, Ko LS, So KL, Ellis T, Lau LT, Yu AC. Detection of highly pathogenic and low pathogenic avian influenza subtype H5 (Eurasian lineage) using NASBA. J. Virol. Methods 103(2), 213-225 (2002).
151. Imai M, Ninomiya A, Minekawa H et al. Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection. Vaccine 24(44-46), 6679-6682 (2006).
152. Spackman E, Senne DA, Myers TJ et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40(9), 3256-3260 (2002).
153. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162(1), 156-159 (1987).
154. Song DS, Lee YJ, Jeong OM et al. Evaluation of a competitive ELISA for antibody detection against avian influenza virus. J. Vet. Sci. 10(4), 323-329 (2009).
155. Muyal JP, Muyal V, Kaistha BP, Seifart C, Fehrenbach H. Systematic comparison of RNA extraction techniques from frozen and fresh lung tissues: checkpoint towards gene expression studies. Diagn. Pathol. 4(1), 9 (2009).
156. van Elden LJ, van Kraaij MG, Nijhuis M et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin. Infect. Dis. 34(2), 177-183 (2002).
157. Borm SV, Steensels M, Ferreira H et al. A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification. Avian Dis. 51(s1), 213-220 (2007).
158. Das A, Spackman E, Senne D, Pedersen J, Suarez DL. Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real-time reverse transcription-PCR with lyophilized reagents. J. Clin. Microbiol. 44(9), 3065-3073 (2006).
159. Bustin SA, Benes V, Garson JA et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55(4), 611-622 (2009).
160. Couch RB. Prevention and treatment of influenza. N. Engl. J. Med. 343(24), 1778-1787 (2000).
161. Barenfanger J. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. J. Clin. Microbiol. 38(8), 2824-2828 (2000).
162. Rahman M, Vandermause MF, Kieke BA, Belongia EA. Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. Diagn. Microbiol. Infect. Dis. 62(2), 162-166 (2008).
163. Chua TH, Ellis TM, Wong CW et al. Performance evaluation of five detection tests for avian influenza antigen with various avian samples. Avian Dis. 51(1), 96-105 (2007).
164. Cui S, Tong G. A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. J. Vet. Diagn. Invest. 20(5), 567-571 (2008).
165. Ho HT, Qian HL, He F et al. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5-and N1-specific monoclonal antibodies. Clin. Vaccine Immunol. 16(5), 726-732 (2009).
166. Wada A, Sakoda Y, Oyamada T, Kida H. Development of a highly sensitive immunochromatographic detection kit for H5 influenza virus hemagglutinin using silver amplification. J. Virol. Methods 178(1), 82-86 (2011).
167. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1), 1465-1468 (1990).
168. Lai WC, Bennett M. DNA vaccines. Crit. Rev. Immunol. 18(5), 449-484 (1998).
169. Gentschev I, Dietrich G, Spreng S et al. Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 19(17-19), 2621-2628 (2001).
170. Mollenkopf H, Dietrich G, Kaufmann SH. Intracellular bacteria as targets and carriers for vaccination. Biol. Chem. 382(4), 521-532 (2001).
171. Husseiny MI, Hensel M. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines. Vaccine 23(20), 2580-2590 (2005).
172. Husseiny MI, Hensel M. Rapid method for the construction of Salmonella enterica serovar Typhimurium vaccine carrier strains. Infect. Immun. 73(3), 1598-1605 (2005).
173. Li L, Fang W, Li J, Huang Y, Yu L. Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by the attenuated Salmonella elicits protective immune responses in chickens. Vaccine 24(33-34), 5919-5927 (2006).
174. Michael A, Stratford R, Khan S, Dalgleish A, Pandha H. Novel strains of Salmonella typhimurium as potential vectors for gene delivery. FEMS Microbiol. Lett. 238(2), 345-351 (2004).
175. Liljebjelke KA, Petkov DI, Kapczynski DR. Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza. Vaccine 28(27), 4430-4437 (2010).
176. Husseiny MI, Hensel M. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins. Vaccine 27(28), 3780-3787 (2009).
177. Husseiny MI, Wartha F, Hensel M. Recombinant vaccines based on translocated effector proteins of Salmonella pathogenicity island 2. Vaccine 25(1), 185-193 (2007).
178. Pan Z, Zhang X, Geng S et al. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 27(7), 1018-1023 (2009)
179. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281(5376), 565-568 (1998).
180. Evans DT, Chen LM, Gillis J et al. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol. 77(4), 2400-2409 (2003).
181. Nishikawa H, Sato E, Briones G et al. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J. Clin. Investig. 116(7), 1946-1954 (2006).
182. Xiong G, Husseiny MI, Song L et al. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. Int. J. Cancer 126(11), 2622-2634 (2010).
183. Xu X, Husseiny MI, Goldwich A, Hensel M. Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines. Infect. Immun. 78(11), 4828-4838 (2010).
184. Swayne DE, Kapczynski D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol. Rev. 225(1), 314-331 (2008).
185. Swayne DE. Avian influenza vaccines and therapies for poultry. Comp. Immunol. Microbiol. Infect. Dis. 32(4), 351-363 (2009).
186. Wuethrich B. Chasing the fickle swine flu. Science 299(5612), 1502-1505 (2003).
187. Zhu Y, Qi X, Cui L, Zhou M, Wang H: Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet 381(9883), 2134 (2013).
188. Lee CW, Suarez DL. Avian influenza virus: prospects for prevention and control by vaccination. Anim. Health Res. Rev. 6(1), 1-15 (2005).
189. Lee SW, Markham PF, Coppo MJC et al. Attenuated vaccines can recombine to form virulent field viruses. Science 337(6091), 188-188 (2012).
190. Fernando GJ, Chen X, Prow TW et al. Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS ONE 5(4), e10266 (2010).
191. Poinern GREJ, Le XT, Shan S et al. Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation. Int. J. Nanomed. 6, 2167-2174 (2011).
192. Comin A, Stegeman J, Klinkenberg D, Busani L, Marangon S. Design and results of an intensive monitoring programme for avian influenza in meat-type turkey flocks during four epidemics in northern Italy. Zoonoses Public Health 58(4), 244-251 (2012).
193. Kelvin AA, Meloni D, Sansonetti P et al. Influenza monitoring in Sardinia, Italy identifies H3 subtype in Mediterranean wild migratory birds. J. Infect. Dev. Ctries 6(11), 786-797 (2012).
194. Lebarbenchon C, Chang C-M, van der Werf S et al. Influenza A virus in birds during spring migration in the Camargue, France. J. Wildl. Dis. 43(4), 789-793 (2007).
195. Lamb RA, Choppin PW. The gene structure and replication of influenza virus. Annu. Rev. Biochem. 52(1), 467-506 (1983).
196. Zell R, Krumbholz A, Eitner A, Krieg R, Halbhuber KJ, Wutzler P. Prevalence of PB1-F2 of influenza A viruses. J. Gen. Virol. 88(2), 536-546 (2007).
197. Chen CJ, Chen GW, Wang CH, Huang CH, Wang YC, Shih S-R. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J. Virol. 84(19), 10051-10062 (2010)
198. Krumbholz A, Philipps A, Oehring H et al. Current knowledge on PB1-F2 of influenza A viruses. Med. Microbiol. Immunol. 200(2), 69-75 (2011).
199. Coleman JR: The PB1-F2 protein of influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol. J. 4(9), 10 (2007).
200. Chen W, Calvo PA, Malide D et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7(12), 1306-1312 (2001).
201. Baigent SJ, Mccauley JW. Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays 25(7), 657-671 (2003).
202. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 26, D49-D53 (2008).
203. Brown EG. Influenza virus genetics. Biomed. Pharmacother. 54(4), 196-209 (2000).
204. Vidic J, Chevalier C, Le Goffic R, Miodek A, Bourdieu C. Surface plasmon resonance immunosensor for detection of PB1-F2 influenza A virus protein in infected biological samples. J. Anal. Bioanal. Tech. S7, 006 (2013).
205. Varga ZT, Palese P. The influenza A virus protein PB1-F2: Killing two birds with one stone? Virulence 2(6), 542-546 (2011).